Celltrion
068270.KS
$120.49
Share price
-2.26%
Change (1 day)
-14.94%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
P/S ratio for Celltrion (068270.KS)
P/S ratio as of March 2025 (TTM): 12.5
According to Celltrion 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.24. At the end of 2024 the company had a P/S ratio of 14.0.
P/S ratio history for Celltrion from 2008 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 14.0 | -30.92% |
| 2023 | 20.3 | 96.25% |
| 2022 | 10.3 | -26.58% |
| 2021 | 14.1 | -50.29% |
| 2020 | 28.3 | 37.99% |
| 2019 | 20.5 | -26.19% |
| 2018 | 27.8 | -8.07% |
| 2017 | 30.3 | 61.89% |
| 2016 | 18.7 | 21.08% |
| 2015 | 15.4 | 91.5% |
| 2014 | 8.06 | -53.24% |
| 2013 | 17.2 | 27.37% |
| 2012 | 13.5 | -29.73% |
| 2011 | 19.3 | -12.41% |
| 2010 | 22.0 | 94.21% |
| 2009 | 11.3 | 1.01% |
| 2008 | 11.2 |